APSR2026-888

 
Late-Breaking
Submitted
Poster Presentation
 
AP01-005
P05
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220909-46904-APSR2026-888_AP01-005_Kayukawa_433262.pdf
Format: PDF Only
02. Cell and Molecular Biology
9

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Takafumi Kayukawa * Nagoya University Department of Respiratory Medicine/Graduate School of Medicine Nagoya Japan
Akira Ando - Nagoya University Department of Respiratory Medicine/Graduate School of Medicine Nagoya Japan
Sho Ota - Nagoya University Department of Respiratory Medicine/Graduate School of Medicine Nagoya Japan
Tomonori Sato - Nagoya University Department of Respiratory Medicine/Graduate School of Medicine Nagoya Japan
Yuki Kondo - Nagoya University Department of Respiratory Medicine/Graduate School of Medicine Nagoya Japan
Yuta Mori - Nagoya University Department of Respiratory Medicine/Graduate School of Medicine Nagoya Japan
Atsushi Enomoto - Nagoya University Department of Molecular Pathology/Graduate School of Medicine Nagoya Japan
Koji Sakamoto - Nagoya University Department of Respiratory Medicine/Graduate School of Medicine Nagoya Japan
Makoto Ishii - Nagoya University Department of Respiratory Medicine/Graduate School of Medicine Nagoya Japan
 
 
 
 
 
 
Presenting Author Details
Takafumi
Kayukawa
kayukawa.takafumi@gmail.com
+819091888155
31-40
Japan
Original Research
Antifibrotic Potential of Vitamin A and D Analogs in Lung Fibroblasts: Targeting the Novel Marker Meflin
Maximum 25 words
Abstract Content
Vitamins A and D, and their synthetic analogs, function beyond simple nutrients by regulating abnormal differentiation and senescence. This study aims to evaluate the impact of these analogs on the pathological phenotypes of TGFb-stimulated lung fibroblasts. Furthermore, we investigate the involvement of Meflin, an undifferentiated mesenchymal cell marker of which antifibrotic properties were recently reported by us.
Primary mouse lung fibroblasts and normal human lung fibroblasts (NHLF; Lonza, CC-2512) were treated with a vitamin D analog (calcipotriol) or a vitamin A analog (tamibarotene) in the presence or absence of TGF-beta. The expressions of fibrotic markers and Meflin were analyzed by qRTPCR and immunoblotting.
Calcipotriol suppressed the TGF-β-induced expression of fibrotic markers (Acta2, Col1a1, Fn1, and Postn) in mouse lung fibroblasts, whereas this effect was not observed with AM80. In addition, calcipotriol induced Meflin expression to a greater extent than tamibarotene in both mouse fibroblasts and NHLFs.
A vitamin D analog suppresses fibrotic responses in lung fibroblasts, showing a stronger induction of Meflin compared to a vitamin A analog Further evaluations using Meflin knockout models are planned to determine whether Meflin acts as a downstream mediator for these anti-fibrotic effects.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Idiopathic pulmonary fibrosis, Vitamin D analog, Meflin
maximum 3 keywords and no abbreviations, separated by commas
The authors declare no conflicts of interest.
190